Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial-Reference-Cited by-同舟云学术

Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

Published:2016-05 Issue:5 Volume:17 Page:642-650
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Planchard David,Kim Tae Min,Mazieres Julien,Quoix Elisabeth,Riely Gregory,Barlesi Fabrice,Souquet Pierre-Jean,Smit Egbert F,Groen Harry J M,Kelly Ronan J,Cho B C,Socinski Mark A,Pandite Lini,Nase Christine,Ma Bo,D'Amelio Anthony,Mookerjee Bijoyesh,Curtis C Martin,Johnson Bruce E

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Missense mutations of the BRAF gene in human lung adenocarcinoma;Naoki;Cancer Res,2002

4. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF;Wan;Cell,2004

5. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors;Dankort;Genes Dev,2007

Cited by 375 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study;Future Oncology;2024-09-03

2. Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies;Heliyon;2024-09

3. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

4. Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer;Frontiers in Pharmacology;2024-07-29

5. Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer: a joint report from KSMO and KSP;Journal of Pathology and Translational Medicine;2024-07-15